Organization · Venture Capital
Truffle Capital
Truffle Capital is an independent European venture capital firm based in Paris, focusing on disruptive technologies in biomedtech and fintech. Founded in 2001, it has raised over €1.2 billion to support innovative companies.
Overview
What Truffle Capital does
What Truffle Capital is
Truffle Capital is an independent European venture capital firm based in Paris, focusing on disruptive technologies in biomedtech and fintech. Founded in 2001, it has raised over €1.2 billion to support innovative companies.
How it participates in the startup ecosystem
The current public profile supports funder and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2001
- Approximate age
- About 25 years
- Structured capabilities
- Funder · Publisher
- Last reviewed
- March 16, 2026
Official channels
Find Truffle Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Truffle Capital as a funder
Investment thesis
European investor focused on disruptive innovation in life sciences and fintech
Focus narrative
Two core verticals: life sciences (medtech, biotech, digital health) and fintech (payments, insurtech, digital banking). Focus on European companies with global potential.
Value beyond capital
Deep sector expertise in life sciences regulatory pathways, European public market IPO support, and strategic corporate partnership development.
Terms and economics
- Typical check
- $2,000,000–$15,000,000
- Sweet spot
- $8,000,000
Focus and fit
- Stages
- Series A · Series B · Series C
- Regions
- EuropeFranceWestern Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 79
- Investments in the last 12 months
- 5
- Last recorded investment
- October 1, 2025
- Recorded notable exits
- Carmat, Vexim, AB Science, and Pixium Vision
Portfolio context
79 portfolio companies with multiple Euronext IPOs including Carmat (artificial heart), Vexim (spinal surgery, acquired), AB Science (oncology), Pixium Vision (bionic vision).
Capability profile
Truffle Capital as a publisher
Editorial focus
Truffle Capital invests primarily in the biomedtech and fintech sectors. In biomedtech, the firm emphasizes radical innovations in medical technology and biotechnology, while in fintech, it focuses on proprietary AI, blockchain, and cybersecurity technologies applied to financial institutions. The firm typically acts as a lead investor and seeks companies with €5 million in recurring revenue and robust growth strategies, investing between €5 million and €15 million per company.
Audience value
Truffle Capital supports innovation and growth in the biomedtech and fintech sectors, providing funding and expertise to help companies achieve significant exits.
Format and cadence
- Content formats
- podcast and research-report
- Primary platform
- Spotify, Apple Podcasts
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Investors · Founders
Flagship work and coverage
Flagship properties
Truffle Capital publishes various content, including 'Truffle Talks', a podcast series featuring insights from industry leaders, and 'Fintech 100', an annual report that serves as a barometer for France's dynamic fintech sector, highlighting key trends and insights.
Common questions
What to know about Truffle Capital
Upseed classifies Truffle Capital under the Venture Capital organization type. Its current public profile includes funder and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 16, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.